-
1
المؤلفون: Kan Gao, Gregory D. Gudleski, Arpana Gupta, Bruce D. Naliboff, Ravi Bhatt, Jonathan P. Jacobs, Jennifer S. Labus, Jacob Brawer, Rebecca Firth, Kirsten Tillisch, Benjamin M. Ellingson, Venu Lagishetty, Emeran A. Mayer, Jeffrey M. Lackner
المصدر: Microbiome, Vol 9, Iss 1, Pp 1-14 (2021)
Microbiome
Microbiome, vol 9, iss 1مصطلحات موضوعية: Microbiology (medical), Oncology, medicine.medical_specialty, 16S, medicine.medical_treatment, Clinical Trials and Supportive Activities, Neuroimaging, Biology, Microbiology, behavioral disciplines and activities, Oral and gastrointestinal, law.invention, White matter, Irritable Bowel Syndrome, Microbial ecology, Randomized controlled trial, law, Clinical Research, Internal medicine, RNA, Ribosomal, 16S, Basal ganglia, Brain-Gut Axis, medicine, Humans, Microbiome, Irritable bowel syndrome, Default mode network, Nutrition, Ribosomal, Cognitive Behavioral Therapy, Ecology, Research, QR100-130, Neurosciences, Outcome prediction, medicine.disease, Gastrointestinal Microbiome, Cognitive behavioral therapy, medicine.anatomical_structure, Mental Health, Medical Microbiology, RNA, Brain-gut-microbiome axis, Digestive Diseases, Mind and Body, Biomarkers
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11dc14853a20c8ae18f699b3020e7b7dTest
https://doaj.org/article/9211767c78c54222a359b868989af16aTest -
2
المؤلفون: Elizabeth A. Maher, Benjamin M. Ellingson, Sung Choe, Saewon Chun, Marta Penas-Prado, Hua Liu, Lori Steelman, Patrick Y. Wen, Jennifer Clarke, Ingo K. Mellinghoff, Katherine B. Peters, Robert J. Young, Shuchi Sumant Pandya, Min Lu, Timothy F. Cloughesy, Howard A. Burris, Macarena I. de la Fuente, Filip Janku, Kha Le, Gregory M. Cote, Islam Hassan
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 27, iss 16
Clin Cancer Resمصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, IDH1, Adolescent, Pyridines, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Diamines, IDH2, Article, Young Adult, Rare Diseases, Clinical Research, Glioma, Internal medicine, Humans, Medicine, Oncology & Carcinogenesis, Aged, Cancer, Brain Neoplasms, business.industry, Neurosciences, Middle Aged, medicine.disease, Isocitrate Dehydrogenase, Confidence interval, Brain Disorders, Brain Cancer, Orphan Drug, Isocitrate dehydrogenase, 6.1 Pharmaceuticals, Mutation, Toxicity, Cohort, Disease Progression, Elevated transaminases, Female, Neoplasm Recurrence, Local, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac86539fe4e5156e90351b80f2f304fTest
https://doi.org/10.1158/1078-0432.ccr-21-0611Test -
3
المؤلفون: Patrick Y. Wen, Jordi Rodon, Timothy F. Cloughesy, Benjamin M. Ellingson, Lars Mueller, Alan G. Olivero, Timothy R. Wilson, Xuyang Lu, Alexandre Coimbra, Kari M. Morrissey, Eudocia Q. Lee, Elizabeth R. Gerstner
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 8
مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Gastroenterology, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Tissue Distribution, Enzyme Inhibitors, Stomatitis, Cancer, Tumor, Brain Neoplasms, TOR Serine-Threonine Kinases, Brain, Glioma, Middle Aged, medicine.anatomical_structure, Local, Oncology, 030220 oncology & carcinogenesis, Disease Progression, Female, Patient Safety, medicine.symptom, Adult, Bradycardia, Pediatric Research Initiative, medicine.medical_specialty, Maximum Tolerated Dose, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Central nervous system, Brain tumor, 03 medical and health sciences, Rare Diseases, Pharmacokinetics, Clinical Research, Internal medicine, Oxazines, Biomarkers, Tumor, medicine, Humans, Oncology & Carcinogenesis, Dosing, Aged, business.industry, Neurosciences, medicine.disease, Brain Disorders, Brain Cancer, Neoplasm Recurrence, Pyrimidines, 030104 developmental biology, Neoplasm Recurrence, Local, Neoplasm Grading, business, Biomarkers, Progressive disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d23963d434c25b55658aaf2cef94cd98Test
https://doi.org/10.1158/1078-0432.ccr-19-2808Test -
4
المؤلفون: Benjamin M. Ellingson, Dana T. Aftab, Tracy T. Batchelor, Robert J. Harris, Raymond Y. Huang, Rivka R. Colen, Elizabeth R. Gerstner, Lauren E. Abrey, Colin Hessel, Kevin Leu, Timothy F. Cloughesy, John de Groot, Gisela Schwab, Davis C. Woodworth, Martin J. van den Bent, Marion Smits, Ararat Chakhoyan, Renske Gahrmann, Whitney B. Pope, Catalina Raymond, Patrick Y. Wen
المساهمون: Radiology & Nuclear Medicine, Internal Medicine, Neurology
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 23, iss 19
Clinical Cancer Research, 23(19), 5745-5756. American Association for Cancer Research Inc.مصطلحات موضوعية: Vascular Endothelial Growth Factor A, Male, Oncology, Cancer Research, Imaging biomarker, Pyridines, Phases of clinical research, Angiogenesis Inhibitors, chemistry.chemical_compound, 0302 clinical medicine, Lomustine, Receptors, Medicine, Anilides, Cancer, Aflibercept, Tumor, Vascular Endothelial Growth Factor, Middle Aged, Bevacizumab, Local, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Biomedical Imaging, Female, medicine.drug, medicine.medical_specialty, Cabozantinib, Recombinant Fusion Proteins, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Article, Disease-Free Survival, Cediranib, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, Biomarkers, Tumor, Humans, Effective diffusion coefficient, Oncology & Carcinogenesis, business.industry, Neurosciences, Evaluation of treatments and therapeutic interventions, Brain Disorders, Brain Cancer, Receptors, Vascular Endothelial Growth Factor, Neoplasm Recurrence, Diffusion Magnetic Resonance Imaging, chemistry, Quinazolines, Neoplasm Recurrence, Local, Glioblastoma, business, Nuclear medicine, Biomarkers, 030217 neurology & neurosurgery
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8bba073dc3ce7c7331b542d1e654786Test
https://doi.org/10.1158/1078-0432.ccr-16-2844Test -
5
المؤلفون: Patrick Y. Wen, Whitney B. Pope, Colin Hessel, Davis C. Woodworth, Gisela Schwab, Phioanh L. Nghiemphu, Robert J. Harris, Lauren E. Abrey, Solmaz Sahebjam, Warren P. Mason, Timothy F. Cloughesy, Albert Lai, Dana T. Aftab, Kevin Leu, Benjamin M. Ellingson, Okkar Zaw
المصدر: Neuro-oncology, vol 19, iss 1
Ellingson, BM; Harris, RJ; Woodworth, DC; Leu, K; Zaw, O; Mason, WP; et al.(2017). Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single-and multicenter trials. NEURO-ONCOLOGY, 19(1), 89-98. doi: 10.1093/neuonc/now187. UCLA: Retrieved from: http://www.escholarship.org/uc/item/7xr4b3kdTestمصطلحات موضوعية: Male, Oncology, Cancer Research, Contrast Media, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Cancer, Univariate analysis, Tumor, Brain Neoplasms, Middle Aged, Prognosis, Tumor Burden, Molecular Imaging, Bevacizumab, Survival Rate, Editorial, Local, 030220 oncology & carcinogenesis, Female, medicine.drug, medicine.medical_specialty, Cabozantinib, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Context (language use), bevacizumab, Irinotecan, Necrosis, 03 medical and health sciences, recurrent, Rare Diseases, cabozantinib, Clinical Research, Internal medicine, Biomarkers, Tumor, medicine, Humans, Oncology & Carcinogenesis, Survival rate, Neoplasm Staging, Retrospective Studies, T1 subtraction, business.industry, glioblastoma, Neurosciences, Retrospective cohort study, Brain Disorders, Surgery, Brain Cancer, Clinical trial, Neoplasm Recurrence, chemistry, tumor volume, Camptothecin, Neurology (clinical), Neoplasm Recurrence, Local, Glioblastoma, business, Biomarkers, 030217 neurology & neurosurgery, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2decfa02dc8d2dd10f659b0e8ed53357Test
https://doi.org/10.1093/neuonc/now187Test -
6
المؤلفون: Joey Orpilla, Lin Du, William H. Yong, Isabel Arrillaga-Romany, Patrick Y. Wen, Howard Colman, Thomas Kaley, Catherine Sanders, Alexander Lee, Sarah C. Gaffey, Tom B. Davidson, Phioanh L. Nghiemphu, Nicholas Butowski, Julie A. Rytlewski, Barbara O’Brien, Eudocia Q. Lee, Anthony C. Wang, Benjamin M. Ellingson, Adam L. Cohen, Robert M. Prins, Ingo K. Mellinghoff, Linda M. Liau, Willy Hugo, Aaron Mochizuki, Timothy F. Cloughesy, David A. Reardon, John de Groot, Jennifer Clarke, Eric S. Kawaguchi, Gang Li
المصدر: Nature medicine, vol 25, iss 3
Transl Cancer Resمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_treatment, T-Lymphocytes, Programmed Cell Death 1 Receptor, Pembrolizumab, Medical and Health Sciences, Neurosurgical Procedures, 0302 clinical medicine, Antineoplastic Agents, Immunological, Cancer immunotherapy, Monoclonal, Tumor Microenvironment, Medicine, Humanized, Neoadjuvant therapy, Adjuvant, Cancer, Brain Neoplasms, General Medicine, Middle Aged, Neoadjuvant Therapy, Survival Rate, Immunological, Local, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, 6.1 Pharmaceuticals, Female, Patient Safety, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Immunology, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, Article, Antibodies, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, Adjuvant therapy, Humans, Chemotherapy, Survival rate, Aged, Tumor microenvironment, business.industry, Neurosciences, Evaluation of treatments and therapeutic interventions, Immunotherapy, Brain Disorders, Brain Cancer, 030104 developmental biology, Neoplasm Recurrence, Immunization, Neoplasm Recurrence, Local, business, Glioblastoma
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3ae39dddd1a3863fed4db0b0d75312Test
https://escholarship.org/uc/item/7gf847t7Test -
7
المؤلفون: Laura Dovek, Timothy F. Cloughesy, Myung-Shin Sim, Albert Lai, Arliene Ravelo, Huy Tram N. Nguyen, Liang Yen Liu, Robert Harris, Byram Ozer, Daniel Lenchner, Richard M. Green, Nhung T Nguyen, Robert Elashoff, Benjamin M. Ellingson, Nicolas Sommer, Phioanh L. Nghiemphu
المصدر: Neuro-oncology practice, vol 6, iss 2
مصطلحات موضوعية: Oncology, medicine.medical_specialty, first recurrence, Bevacizumab, Large tumor, overall survival, Clinical Trials and Supportive Activities, Medicine (miscellaneous), bevacizumab, 03 medical and health sciences, 0302 clinical medicine, Rare Diseases, Clinical Research, Internal medicine, Overall survival, Medicine, First Recurrence, Radio chemotherapy, Cancer, Tumor size, business.industry, tumor size, glioblastoma, Neurosciences, Lomustine, Original Articles, medicine.disease, Brain Disorders, Brain Cancer, 030220 oncology & carcinogenesis, 6.1 Pharmaceuticals, business, 030217 neurology & neurosurgery, medicine.drug, Glioblastoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5eb25c25c268ce6c066359814f88fcdTest
https://escholarship.org/uc/item/03j1n5pdTest -
8
المؤلفون: Olivier Chinot, Whitney B. Pope, Tracy T. Batchelor, Roger Henriksson, Sarah J. Nelson, Jennie Taylor, Susan M. Chang, Patrick Y. Wen, Arnav Mehta, Elizabeth R. Gerstner, Ryo Nishikawa, Brian M. Alexander, Timothy J. Kaufmann, Ingo K. Mellinghoff, Benjamin M. Ellingson, Keith L. Ligon, Howard Colman, John de Groot, Josep Garcia, Robert J. Young, Frank Saran, Warren P. Mason, Nicholas Butowski, Raymond Y. Huang, Isabel Arrillaga-Romany, Evanthia Galanis, Timothy F. Cloughesy, Lauren E. Abrey, Michael D. Prados, Wolfgang Wick, David A. Reardon, Rivkah Colen
المساهمون: Département de neurooncologie, Hôpital de la Timone [CHU - APHM] (TIMONE), Department of Radiation Sciences, Oncology, Umeå University, Department of Neurooncology, Heidelberg University Hospital [Heidelberg], Hadassah Hebrew University Medical Center [Jerusalem], Massachusetts General Hospital [Boston], Loughborough University, School of Environment and Technology, University of Sussex, Department of Molecular Medicine, Mayo Clinic, Hôpital de la Timone [CHU - APHM] ( TIMONE ), Massachusetts General Hospital [Boston] ( MGH )
المصدر: Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2018, ⟨10.1093/neuonc/noy053⟩
Neuro-Oncology, Oxford University Press (OUP), 2018, 〈10.1093/neuonc/noy053〉
Neuro-oncology, vol 20, iss 9
Ellingson, BM; Abrey, LE; Nelson, SJ; Kaufmann, TJ; Garcia, J; Chinot, O; et al.(2018). Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. NEURO-ONCOLOGY, 20(9), 1240-1250. doi: 10.1093/neuonc/noy053. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0v78z01zTestمصطلحات موضوعية: Oncology, Male, Cancer Research, contrast-enhancing tumor volume, [SDV]Life Sciences [q-bio], Contrast Media, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, ComputingMilieux_MISCELLANEOUS, Cancer, Vorinostat, Chemoradiotherapy, Middle Aged, Prognosis, Magnetic Resonance Imaging, 3. Good health, Survival Rate, 030220 oncology & carcinogenesis, Residual, 6.1 Pharmaceuticals, Female, medicine.drug, medicine.medical_specialty, Prognostic factor, Bevacizumab, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Newly diagnosed, bevacizumab, Imaging data, GBM, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, medicine, Overall survival, Temozolomide, Humans, Oncology & Carcinogenesis, Retrospective Studies, Postoperative Care, clinical trials, [ SDV ] Life Sciences [q-bio], business.industry, T1 subtraction, Neurosciences, O-6-methylguanine-DNA methyltransferase, Evaluation of treatments and therapeutic interventions, medicine.disease, Image Enhancement, new glioblastoma, nervous system diseases, Brain Disorders, Clinical trial, Brain Cancer, Neoplasm, Neurology (clinical), business, Glioblastoma, 030217 neurology & neurosurgery, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5bde2fd7ff93ddc9c95a933bfa0dc0aTest
https://hal-amu.archives-ouvertes.fr/hal-01814367Test